However, as in EMPA-REG the individual effects on CV death, non-fatal MI, or non-fatal stroke did not reach statistical significance.
← all excerpts
The expanding role of SGLT2 inhibitors beyond glucose-lowering to cardiorenal protection.
1
—
—
However, as in EMPA-REG the individual effects on CV death, non-fatal MI, or non-fatal stroke did not reach statistical significance.